Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.5T | 2.7T | 2.3T | 2.5T |
Cost of revenue | 2.3T | 2.4T | 2.1T | 2.3T |
Gross profit | 237.6B | 295.6B | 227.4B | 233.0B |
Operating expense | ||||
Research & development | — | 28.0B | 19.3B | 18.1B |
Selling general and admin | 114.5B | 56.5B | 50.3B | 50.4B |
Other operating expenses | — | 3.0B | 5.7B | 1.5B |
Operating income | 237.6B | 174.2B | 119.9B | 130.7B |
Non operating interest income | ||||
Income | — | 4.8B | 3.6B | 7.8B |
Expense | — | 52.9B | 53.8B | 54.3B |
Other income expense | — | — | — | — |
Pretax income | 90.9B | -478.4B | 71.7B | 76.0B |
Tax provision | 766.0M | -379.0B | 288.9M | 2.0B |
Net income | 90.1B | -99.4B | 71.4B | 74.0B |
Basic EPS | 107.8 | — | 87 | 90 |
Diluted EPS | 107.8 | — | 87 | 90 |
Basic average shares | — | — | 850.3M | 850.6M |
Diluted average shares | — | — | 850.3M | 850.6M |
EBITDA | 237.6B | 361.1B | 170.4B | 254.7B |
Net income from continuing op. | — | -109.0B | 71.7B | 76.0B |
Minority interests | 2.0B | 2.8B | 2.6B | 2.6B |
Preferred stock dividends | — | — | — | — |